Contact Us

Vivo Ventures
575 High Street, Suite 201
Palo Alto, CA 94301
(650) 688-0818 Phone
(650) 688-0815 Fax
info@vivoventures.com
Map of Vivo Ventures
Street Parking is available along both High and Hamilton Street
Vivo Ventures Map
Directions to Vivo Ventures

From SFO
  1. Start out going East on DOMESTIC TERMINAL toward AIRPORT EXIT. (0.1 miles)
  2. Turn LEFT onto AIRPORT EXIT. (0.1 miles)
  3. Merge onto US-101 S toward SAN JOSE. (17.2 miles)
  4. Take the WILLOW ROAD exit toward MENLO PARK. (0.2 miles)
  5. Turn RIGHT onto WILLOW RD. (1.0 miles)
  6. Turn LEFT onto MIDDLEFIELD RD. (0.4 miles)
  7. Turn RIGHT onto UNIVERSITY AVE. (0.5 miles)
  8. Turn LEFT onto HIGH ST. (0.1 miles)
  9. End at 575 HIGH ST. PALO ALTO, CA
  10.  
  From SJC
  1. Start out going Northwest on AIRPORT BLVD toward TERMINAL C. (0.1 miles)
  2. Turn RIGHT onto AIRPORT PKWY. (0.1 miles)
  3. Turn LEFT onto ramp. (0.2 miles)
  4. Merge onto GUADALUPE PKWY/CA-87 N. (0.1 miles)
  5. Merge onto US-101 N toward SAN FRANCISCO. (13.4 miles)
  6. Take the UNIVERSITY AVE exit toward PALO ALTO. (0.2 miles)
  7. Merge onto UNIVERSITY AVE. (2.0 miles)
  8. Turn LEFT onto HIGH ST. (0.1 miles)
  9. End at 575 HIGH ST. PALO ALTO, CA
  10.  

News & Events

SPECTRAGENICS ANNOUNCES $30M IN NEW FUNDING CHANGES COMPANY NAME TO TRIA BEAUTY
Pleasanton, CA - July 10, 2008

AVANIR to Raise $40.0 Million to Fund Zenvia Through Clinical Development and Regulatory Approval
Aliso Viejo, CA - March 27, 2008

Carbylan Announces $20 Million Series B Financing
Palo Alto, CA - Nov 26, 2007

Yaupon Therapeutics closes $14.5 million financing -- Series C financing positions company to advance development of its product portfolio targeting cancer and central nervous system diseases
Radnor, PA - Nov 26, 2007

BioForm Announces Pricing of Initial Public Offering
SAN MATEO, CA - Nov 07, 2007

Vivo Ventures Expands Team with the Addition of James Huang as an Executive in Residence
Palo Alto, CA October 24, 2007 Vivo Ventures

APT Pharmaceuticals Closes New $22 Million Funding Round
Burlingame, CA - October 4, 2007

Sagent Pharmaceuticals Inc. Completes $53M Series A Financing
Schaumburg, IL - September 27, 2007

Acura Pharmaceuticals, Inc. secures financing to fund pivotal Phase III clinical trial for lead Aversion® technology product candidate
Palatine, IL - August 20, 2007

Capnia names chairman, CEO
Palo Alto, CA - August 6, 2007

Biodel Inc. Announces Completion of Public Offering
Danbury, CT - May 17, 2007

Vivo Ventures Announces the Closing of Vivo Ventures Fund VI, a $275M Life Science Venture Fund
Palo Alto, CA - May 7, 2007

TransOral Pharmaceuticals Raises $40 Million in Series D Financing
Pt. Richmond, CA - March 6, 2007

Synapse BioMedical Completes Series C Private Equity Financing
Cleveland, OH, January 16, 2007

InteKrin Therapeutics Secures $23 M Venture Financing
Palo Alto, CA, January 11, 2007

Biodel Inc. Raises $21 Million in Series B Financing
Danbury, CT, August 2, 2006

Naryx Pharma Completes Series B2 Private Equity Financing
Santa Barbara, CA, May 22, 2006